✦ LIBER ✦

A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer

✍ Scribed by Hudes, Gary; Tagawa, Scott T.; Whang, Young E.; Qi, Ming; Qin, Xiang; Puchalski, Thomas A.; Reddy, Manjula; Cornfeld, Mark; Eisenberger, Mario

Book ID: 121637892
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 208 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-012-9857-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised phase II study of siltuximab

Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer

✍ K. Fizazi; J.S. De Bono; A. Flechon; A. Heidenreich; E. Voog; N.B. Davis; Ming Q 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Phase I trial with a combination of doce

Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer

✍ Jianqing Lin; Victoria J. Sinibaldi; Michael A. Carducci; Samuel Denmeade; Danny 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 296 KB

A phase 1/1b study of satraplatin (JM-21

A phase 1/1b study of satraplatin (JM-216) in combination with docetaxel in patients with advanced solid tumors and metastatic castrate-resistant prostate cancer

✍ Cetnar, Jeremy; Wilding, George; McNeel, Douglas; LoConte, Noelle K.; McFarland, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 172 KB

A phase I study of oral panobinostat alo

A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer

✍ Dana Rathkopf; Bryan Y. Wong; Robert W. Ross; Aseem Anand; Erika Tanaka; Margare 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 378 KB

Phase I study of sorafenib in combinatio

Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer

✍ Feby Mardjuadi, Jacques Medioni, Joseph Kerger… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 305 KB

4025 POSTER A phase I/II study of suniti

4025 POSTER A phase I/II study of sunitinib in combination with docetaxel (dcx) and prednisone (pdn) in patients with metastatic castrate-resistant prostate cancer (mCRPC)

✍ A. Zurita; N.D. Shore; M.F. Kozloff; C.W. Ryan; T.M. Beer; E. Chow Maneval; I. C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB